-
公开(公告)号：US11975006B2
公开(公告)日：2024-05-07
申请号：US18308723
申请日：2023-04-28
IPC分类号： A61K31/4985 , A61K9/08 , A61K31/519 , A61K47/10
CPC分类号： A61K31/519 , A61K9/08 , A61K31/4985 , A61K47/10
摘要： The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
公开(公告)号：US11337979B2
公开(公告)日：2022-05-24
申请号：US17403355
申请日：2021-08-16
IPC分类号： A61K31/519 , A61K31/4985 , A61K47/10 , A61K9/08
摘要： The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
公开(公告)号：US12005062B2
公开(公告)日：2024-06-11
申请号：US18365266
申请日：2023-08-04
IPC分类号： A61K31/4985 , A61K9/08 , A61K31/519 , A61K47/10
CPC分类号： A61K31/519 , A61K9/08 , A61K31/4985 , A61K47/10
摘要： The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
公开(公告)号：US11759468B2
公开(公告)日：2023-09-19
申请号：US17823546
申请日：2022-08-31
IPC分类号： A61K31/519 , A61K31/4985 , A61K47/10 , A61K9/08
CPC分类号： A61K31/519 , A61K9/08 , A61K31/4985 , A61K47/10
摘要： The present disclosure is directed to pharmaceutical compositions comprising sildenafil or a pharmaceutically acceptable salt thereof and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of sildenafil or a pharmaceutically acceptable salt thereof such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
公开(公告)号：US11666576B2
公开(公告)日：2023-06-06
申请号：US17832921
申请日：2022-06-06
IPC分类号： A61K31/4985 , A61K47/10 , A61K31/519 , A61K9/08
CPC分类号： A61K31/519 , A61K9/08 , A61K31/4985 , A61K47/10
摘要： The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
公开(公告)号：US11918684B2
公开(公告)日：2024-03-05
申请号：US16494030
申请日：2018-03-12
CPC分类号： A61K9/0095 , A61K9/0053 , A61K9/10 , A61K47/02 , A61K47/10 , A61K47/14 , A61K47/26 , A61K47/36
摘要： The present invention provides pharmaceutical composition of immunosuppressive agent in oral suspension dosage form. The oral suspension composition comprises of immunosuppressive agent with other pharmaceutical excipients such as vehicle, suspending agent, solvent or cosolvent, preservative, sweetener, antifoaming agent, wetting agent, buffering agent and flavouring agent. The present invention oral suspension having improved stability, palatability with high dose of active ingredient. The present invention provides oral suspension with flavor that has masked bitter taste of the drug and eliminates difficulty of administration. Further, the present invention also provides a convenient, easy process for preparation thereof.
-
公开(公告)号：US11464778B2
公开(公告)日：2022-10-11
申请号：US16957894
申请日：2018-12-24
IPC分类号： A61K31/519 , A61K9/08 , A61K47/10 , A61K31/4985
摘要： The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
公开(公告)号：US11382917B2
公开(公告)日：2022-07-12
申请号：US17403282
申请日：2021-08-16
IPC分类号： A61K31/519 , A61K31/4985 , A61K47/10 , A61K9/08
摘要： The present disclosure is directed to pharmaceutical compositions comprising a PDE V inhibitor and one or more pharmaceutical excipients or additives wherein the pharmaceutical compositions are in the form of liquid pharmaceutical compositions. The pharmaceutical compositions of the present disclosure are useful for the treatment of diseases or conditions which are treatable by administration of PDE V inhibitor drug such as pulmonary arterial hypertension, erectile dysfunction, etc.
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.02 秒)
